Results 201 to 210 of about 94,345 (348)
Model‐informed drug development (MIDD) played a crucial role in the successful development and regulatory approval of daprodustat, a novel oral hypoxia‐inducible factor prolyl hydroxylase (HIF‐PHI) inhibitor aimed at treating anemia in chronic kidney disease patients.
Kelly M. Mahar +6 more
wiley +1 more source
Hemoglobin and human longevity: integrating oxygen transport, redox biology, and aging pathways - a narrative review. [PDF]
Obeagu EI.
europepmc +1 more source
ABSTRACT Whether fat oxidation (FATox) is altered during exercise in hypoxia remains equivocal due to differences in experimental protocols. Furthermore, to date no investigation has reported the effect of hypoxia on maximal fat oxidation rate (MFO).
Youmna Elsayed Hassanein +3 more
wiley +1 more source
Retraction: Investigating the relationship between erythropoiesis-stimulating agents and mortality in hemodialysis patients: A systematic review and meta-analysis. [PDF]
PLOS One Editors.
europepmc +1 more source
ABSTRACT Background and Aims Lower income European countries (LIECs) have more limited financial resources to cover high‐cost technologies in rare diseases than higher income European countries (HIECs). Our study explores how treatment recommendations in myelodysplastic syndrome (MDS) can be supported in LIECS by transferring real‐world evidence (RWE ...
Zoltán Kaló +25 more
wiley +1 more source
Prpf4 sequentially regulates the expansion and maturation of erythrocyte through distinct mechanisms. [PDF]
Deng Z +11 more
europepmc +1 more source
Hydrolyzed Milk-Derived Peptides Promote Erythropoietin Pathways and Hematologic Recovery: A Cross-Species Analysis. [PDF]
Zang L +5 more
europepmc +1 more source
Fetal erythropoiesis and hemoglobin regulation in the context of maternal obesity
Zhongyun Kou +9 more
openalex +1 more source

